Literature DB >> 8780740

A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier.

J M Varley1, M Thorncroft, G McGown, K Tricker, J M Birch, D G Evans.   

Abstract

We report here a family with some of the characteristics of Li-Fraumeni syndrome (Li-Fraumeni-like) in which there is a 2 base pair deletion within exon 6 of TP53 in two affected individuals. Of particular interest in this family is a study of loss of heterozygosity (LOH) of the TP53 gene, and the finding that there is LOH in all cancers available for study from mutation carriers, and additionally from a benign endometrial polyp from one of those patients. Two other family members, one with a rectal carcinoma aged 55, the other with two separate benign lesions under the age of 45, were both wild-type for the TP53 mutation.

Entities:  

Mesh:

Year:  1996        PMID: 8780740     DOI: 10.1016/0165-4608(96)00059-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  The role of p53 in human cancer.

Authors:  D Malkin
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.

Authors:  J M Varley; G McGown; M Thorncroft; L A James; G P Margison; G Forster; D G Evans; M Harris; A M Kelsey; J M Birch
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

3.  TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.

Authors:  Raissa Coelho Andrade; Anna Claudia Evangelista Dos Santos; Joaquim Caetano de Aguirre Neto; Julián Nevado; Pablo Lapunzina; Fernando Regla Vargas
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 4.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.